Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Loxahatchee › NPI 1528014669
Hospital

Palms West Hospital Limited Partnership

Palms West Hospital Limited Partnership was paid $15.92M by Medicaid between Jan 2018 and Dec 2024, across 206 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.

33Billing provider infoPALMS WEST HOSPITAL LIMITED PARTNERSHIP
LOXAHATCHEE, FL 33470
33aNPI1528014669assigned 05/26/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.92M
24GClaims622,063
24DCodes billed206
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#27 of 163
Median peer was paid$4.77M
This provider vs. median3.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201834,687$489K
2019127,029$2.05M
202075,216$1.45M
2021112,034$2.93M
2022134,004$4.15M
202395,333$2.98M
2024incomplete43,760$1.87M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 26% 45,057 41,853 $4.20M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 30,106 26,759 $1.94M
99282 Emergency department visit for the evaluation and management, low to moderate severity 8.2% 15,278 14,483 $1.31M
80053 Comprehensive metabolic panel 6.6% 20,071 16,219 $1.05M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.4% 10,550 7,548 $1.02M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 3.7% 6,212 1,527 $587K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.6% 3,113 2,729 $576K
70450 Computed tomography, head or brain; without contrast material 3.4% 4,255 3,758 $536K
97530 Therapeutic activities, direct patient contact, each 15 minutes 3.1% 4,834 1,390 $494K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.7% 4,215 1,247 $436K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.4% 3,137 3,017 $375K
80048 Basic metabolic panel (calcium, ionized) 2.2% 14,714 11,452 $358K
194 more codes
87275 1.4% 23,385 $219K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.3% 1,750 $203K
76705 Ultrasound, abdominal, real time with image documentation; limited 1.1% 2,288 $171K
G0378 Hospital observation service, per hour 1.0% 16,053 $159K
71275 Computed tomographic angiography, chest, with contrast material <1% 806 $159K
87070 <1% 10,469 $154K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 17,448 $126K
87088 <1% 10,572 $85K
93975 <1% 3,773 $83K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,310 $76K
71046 Radiologic examination, chest; 2 views <1% 11,072 $70K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,519 $66K
85027 <1% 39,845 $64K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 470 $62K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 433 $61K
76819 Fetal biophysical profile; without non-stress testing <1% 1,194 $55K
81001 <1% 17,096 $53K
96361 Intravenous infusion, hydration; each additional hour <1% 1,219 $50K
80047 <1% 1,914 $48K
72125 Computed tomography, cervical spine; without contrast material <1% 645 $47K
76830 Ultrasound, transvaginal <1% 784 $45K
76775 <1% 616 $45K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 708 $41K
81003 <1% 9,225 $39K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 747 $39K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,033 $37K
36415 Collection of venous blood by venipuncture <1% 1,596 $37K
74018 <1% 2,737 $36K
A9270 Non-covered item or service <1% 5,807 $35K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,152 $35K
84702 <1% 3,540 $25K
81025 <1% 12,647 $25K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 219 $23K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,365 $23K
86850 <1% 3,200 $22K
71045 Radiologic examination, chest; single view <1% 7,564 $22K
12011 <1% 270 $20K
97163 <1% 434 $19K
80076 <1% 6,651 $17K
74019 <1% 1,280 $17K
87807 <1% 8,138 $16K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,168 $15K
87077 <1% 1,843 $15K
73610 <1% 870 $14K
73070 <1% 538 $14K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 191 $14K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 14,759 $13K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,464 $12K
85610 <1% 7,719 $12K
S0028 Injection, famotidine, 20 mg <1% 1,455 $12K
85730 <1% 7,644 $12K
73562 <1% 845 $12K
S5010 5% dextrose and 0.45% normal saline, 1000 ml <1% 14 $9K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,068 $9K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 10,141 $9K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 7,168 $9K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 955 $8K
73630 <1% 795 $8K
86140 <1% 7,065 $8K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,760 $8K
70491 <1% 32 $8K
J1644 Injection, heparin sodium, per 1000 units <1% 1,583 $7K
84484 <1% 6,842 $7K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 11,844 $7K
87045 <1% 269 $7K
73110 <1% 462 $7K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,639 $7K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,308 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,144 $6K
J2704 Injection, propofol, 10 mg <1% 1,427 $6K
J7030 Infusion, normal saline solution , 1000 cc <1% 11,154 $6K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 190 $6K
87040 <1% 6,882 $6K
74240 <1% 102 $5K
83735 <1% 2,211 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,559 $5K
86900 <1% 3,672 $5K
73130 <1% 547 $5K
J3490 Unclassified drugs <1% 476 $5K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 152 $4K
93971 <1% 310 $4K
96368 <1% 45 $4K
01922 <1% 50 $4K
73030 <1% 315 $4K
86901 <1% 4,855 $4K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 6,868 $4K
76870 <1% 24 $3K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 334 $3K
12001 <1% 56 $3K
72100 <1% 148 $3K
76801 <1% 710 $3K
76857 <1% 944 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 18 $2K
83880 <1% 1,455 $2K
86780 <1% 65 $2K
87276 <1% 23,379 $2K
82550 <1% 1,545 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,141 $2K
82272 <1% 47 $2K
70551 Magnetic resonance imaging, brain; without contrast material <1% 33 $2K
73090 <1% 204 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,161 $2K
70486 <1% 16 $2K
92523 <1% 13 $2K
74241 <1% 18 $1K
96375 Therapeutic injection; each additional sequential IV push <1% 5,048 $1K
72131 <1% 63 $1K
83690 <1% 7,833 $1K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 75 $1K
29125 <1% 55 $985.74
C1769 Guide wire <1% 55 $943.94
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,420 $900.98
84443 Thyroid stimulating hormone (TSH) <1% 1,155 $874.02
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,612 $871.92
82247 <1% 493 $840.26
84703 <1% 471 $813.91
87210 <1% 43 $731.89
84112 <1% 90 $723.80
83605 <1% 2,847 $690.11
82040 <1% 397 $687.79
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 208 $679.41
88342 <1% 320 $666.20
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 125 $616.49
73590 <1% 73 $533.02
85379 <1% 867 $488.32
84450 <1% 396 $402.41
84460 <1% 396 $402.41
84155 <1% 396 $402.41
84075 <1% 396 $402.41
85014 <1% 18 $346.86
00813 <1% 31 $339.12
83036 Hemoglobin; glycosylated (A1C) <1% 254 $338.58
73140 <1% 17 $277.02
88304 <1% 627 $257.22
82728 <1% 216 $227.77
J7050 Infusion, normal saline solution, 250 cc <1% 1,782 $190.29
82570 <1% 13 $176.43
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 972 $175.10
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 208 $171.19
84550 <1% 311 $129.03
70210 <1% 41 $118.41
82248 <1% 1,979 $88.66
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 29 $65.66
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 278 $65.16
87205 <1% 600 $64.47
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 38 $60.91
86308 <1% 158 $57.53
J0690 Injection, cefazolin sodium, 500 mg <1% 132 $54.45
80061 Lipid panel <1% 149 $48.48
86738 <1% 178 $45.28
85652 <1% 1,802 $39.82
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 221 $16.67
J1815 Injection, insulin, per 5 units <1% 368 $15.43
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 86 $15.08
86920 <1% 27 $9.12
84439 <1% 89 $7.68
96376 <1% 53 $5.06
80320 <1% 60 $4.89
87186 <1% 148 $3.97
87075 <1% 47 $1.84
82150 <1% 97 $1.77
00840 <1% 148 $1.56
84100 <1% 259 $1.56
00731 <1% 30 $1.17
72040 <1% 31 $0.92
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 27 $0.46
86923 0% 47 $0.00
83540 0% 66 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 86 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 330 $0.00
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program 0% 64 $0.00
85045 0% 169 $0.00
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 0% 85 $0.00
S0077 Injection, clindamycin phosphate, 300 mg 0% 64 $0.00
86665 0% 13 $0.00
86663 0% 13 $0.00
85384 0% 20 $0.00
82009 0% 12 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 17 $0.00
00170 Anesthesia for intraoral procedures, including biopsy 0% 32 $0.00
97116 0% 22 $0.00
41899 Unlisted procedure, dentoalveolar structures 0% 33 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 26 $0.00
J2060 Injection, lorazepam, 2 mg 0% 32 $0.00
82077 0% 72 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 103 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 15 $0.00
84157 0% 45 $0.00
J0561 Injection, penicillin g benzathine, 100,000 units 0% 33 $0.00
85018 0% 14 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 13 $0.00
86664 0% 13 $0.00
83615 0% 19 $0.00
73502 0% 20 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRODRIGUEZ, ONEL (CFO)